Evidence map›Paper›PMID 26902768›Full record

ArticleAntimicrobial agents and chemotherapy2016

The Central Hinge Link Truncation of the Antimicrobial Peptide Fowlicidin-3 Enhances Its Cell Selectivity without Antibacterial Activity Loss.

Pei Qu, Wei Gao, Huixian Chen, Dan Li, Na Yang, Jian Zhu, Xingjun Feng, Chunlong Liu, Zhongqiu Li

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Anti-Antibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antimicrobial Peptides: An Update on Classifications and Databases.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pei QuCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, People's Republic of China.
Wei GaoCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, People's Republic of China.
Huixian ChenCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, People's Republic of China.
Dan LiCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, People's Republic of China.
Na YangCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, People's Republic of China.
Jian ZhuCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, People's Republic of China.
Xingjun FengCollege of Animal Science and Technology, Northeast Agricultural University, Harbin, People's Republic of China fengxingjun@neau.edu.cn liuchunlong1976@163.com.
Chunlong LiuNortheast Institute of Geography and Agricultural Ecology, Chinese Academy of Sciences, Harbin, People's Republic of China Collaborative Innovation Center for Development and Utilization of Forest Resources, Harbin, People's Republic of China fengxingjun@neau.edu.cn liuchunlong1976@163.com.
Zhongqiu LiAnimal Husbandry Research Centre of Heilongjiang Academy of Agricultural Science, Harbin, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) have been paid considerable attention because of their broad-spectrum antimicrobial activity and a reduced possibility of the development of bacterial drug resistance. Fowlicidin-3 (Fow-3) is an identified type of chicken cathelicidin AMP that has exhibited considerable antimicrobial activity and cytotoxicity. To reduce cell toxicity and improve cell selectivity, several truncated peptides of fowlicidin-3, Fow-3(1-15), Fow-3(1-19), Fow-3(1-15-20-27), and Fow-3(20-27), were synthesized. Our results indicated that neither the N- nor C-terminal segment alone [Fow-3(1-15), Fow-3(1-19), Fow-3(20-27)] was sufficient to confer antibacterial activity. However, Fow-3(1-19) with the inclusion of the central hinge link (-AGIN-) retained substantial cell toxicity, which other analogs lost. Fow-3(1-15-20-27) displayed potent antimicrobial activity for a wide range of Gram-negative and Gram-positive bacteria and no obvious hemolytic activity or cytotoxicity. The central link region was shown to be critically important in the function of cell toxicity but was not relevant to antibacterial activity. Fow-3(1-15-20-27) maintained antibacterial activity in the presence of physiological concentrations of salts. The results from fluorescence spectroscopy, scanning electron microcopy, and transmission electron microcopy showed that Fow-3(1-15-20-27) as well as fowlicidin-3 killed bacterial cells by increasing membrane permeability and damaging the membrane envelope integrity. Fow-3(1-15-20-27) could be a promising antimicrobial agent for clinical application.

Indexed as

AnimalsAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial Cationic PeptidesCell LineCell Membrane PermeabilityChickensHemolysisHumansMicrobial Sensitivity TestsMicroscopy, Electron, ScanningMicroscopy, Electron, TransmissionPeptidesAnti-Bacterial AgentsAnti-Infective AgentsAntimicrobial Cationic Peptidesfowlicidin-3, chickenPeptides

Identifiers

PMID26902768
PMCPMC4862537

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.